Rowatinex Soft Capsules

Product Information

Colica renala severa, anurie, infectii grave ale tractului urinar, litiaza urinara care necesita tratament chirurgical. Should not be used in patients receiving oral anti-coagulants or other drugs metabolised by the liver where dose is critical. 4.6 Pregnancy and lactation

Doza uzuala este de o capsula Rowatinex de 3-4 ori pe zi, cu 30 de minute inainte de mese sau conform recomandarii medicului. active substances or any of the other ingredients of Rowatinex® (see section 6 “Further information” for details). Skład: Jedna kapsułka zawiera: alfa-pinenum 24,8 g, beta-pinenum 6,2 g, camphennum 15,0 g, cineolum 3,0 g, fenchonum 4,0 g borneolum 10,0 g anetholum 4,0 g. Substancje pomocnicze: olej z oliwek 33 g. Powłoczka kapsułki: żelatyna wołowa, glicerol 85%, etylu parahydroksybenzoesan (E 214), propylu parahydroksybenzoesan (E 216), żółcień pomarańczowa FCF 85% (E 110), żółcień chinolinowa WS 70% (E 104). Commissioners and/or providers have a responsibility to provide the funding required to enable the guidance to be applied when individual health professionals and their patients wish to use it, in accordance with the NHS Constitution. They should do so in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. DO NOT take Rowatinex ® if you are allergic (hypersensitive) to any of the active substances or any of the other ingredients of Rowatinex® (see section 6 “Further information” for details).

Prospect Rowatinex x 30 caps.

Desi nu s-au raportat efecte teratogene, Rowatinex nu trebuie administrat in primul trimestru de sarcina. Deoarece nu sunt disponibile INFORMATII suficiente, Rowatinex nu trebuie administrat femeilor care alapteaza. Rowatinex® relieves muscle spasm thus reducing the pain of kidney and urinary colics. Rowatinex® is also used to relieve the effects associated withmild urinary tract infections. 2. Before you take Rowatinex® Although no teratogenic effects have been reported, ROWATINEX should not be given in the first trimester of pregnancy. Although no evidence is available,ROWATINEX should not be given to lactating females. 4.7 Effects on ability to drive and use machines Rowatinex® Capsules are yellow, ball shaped (spherical), soft gelatine capsules. The capsules are gastro-resistant. This means they only releasethe medicine in the intestine, not the stomach.

Terpenes such as Borneol are substantially metabolised in man and animals to their glucuronides which are eliminated in the urine. 5.3 Preclinical safety data After Chaussy et al. [ 3] introduced SWL for the treatment of urinary stones in 1980, SWL has become the primary treatment modality for urinary stones. SWL is a noninvasive treatment of urinary stones. However, stone expulsion does not occur immediately after SWL; rather, the debris is released slowly for about 1 month. The remnant stones may cause obstruction, recurrent infection, or calculus regrowth [ 7].Do not take a double dose to make up for a forgotten dose. Just take it as soon as you remember. Then go on taking your next dose at the usualtime.